| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |